Phase 2 Start
WOK: Phase 2 Start: A Prospective, Multicenter, Open-label Two Cohort Study Evaluating the Safety and Efficacy of Select
October 1, 2026. BioSniper AI can trace the company-impact path without requiring you to write the research question.
- Event date
- October 1, 2026
- Company
- WORK Medical Technology Group LTD (WOK)
BioSniper AIPage evidence connected
Prepared research question
What could this event change, and which evidence should be watched next?
Run cited research
Traceable citations · Unknowns marked
Phase 2 Start~month
Phase 2 Start: A Prospective, Multicenter, Open-label Two Cohort Study Evaluating the Safety and Efficacy of Select
- Indication
- Hepatocellular Carcinoma (HCC)